Skip to main content
Clinical Trials/NCT03743467
NCT03743467
Unknown
N/A

Study Regarding the Realization of a Standardized Protocol for the Evaluation of the Visual Condition in Parkinson's Disease

Neuromed IRCCS2 sites in 1 country90 target enrollmentNovember 5, 2018

Overview

Phase
N/A
Intervention
Not specified
Conditions
Parkinson Disease
Sponsor
Neuromed IRCCS
Enrollment
90
Locations
2
Primary Endpoint
Inspection of orthoptic condition in patients with PD
Last Updated
7 years ago

Overview

Brief Summary

Non motor symptoms and signs in Parkinson's disease (PD) also include a series of visual deficits; deepening these aspects could be useful for a better management of symptoms, to standardize a specific protocol for the issues related to vision and also to understand how these aspects are important for the understanding of the mechanisms underlying the PD.

Detailed Description

In Parkinson's disease (PD) several non-motor signs and symptoms already occur in the early stages of the disease; the symptoms are diverse and these also involve visual difficulties which commonly affect the majority of patients and which gradually worsen the quality of life. The most common malfunction produced by PD is the dysfunction of dopaminergic pathways that may be responsible for a series of visual deficits too: * decreased visual acuity and decreased sensibility to light and color, * strabismus and forms of sensory and eye movement dysfunctions, * eyelid dysfunctions and dry eye syndrome Moreover, in patients affected by PD, typical retinal features were discovered for the first time in 2004 by the use of OCT (Optical Coherence Tomography) such as: * the reduction of the retinal nerve fiber layer (RNFL) * a typical thinning of the macular thickness, even if with different results. In the follow-up of the PD, these retinal features, verifiable by the use of OCT, could be considered as a marker of the pathology. For these reasons it may be useful: * quantify in an objective manner how much the visual aspects affect the overall deterioration of the quality of life in patients with PD * demonstrate the validity of a specific and integrated outpatient diagnostic protocol for the study of visual and ophthalmological disorders in patients with PD * demonstrate the diagnostic role of early changes in macular thickness and of the optic disc in subjects suffering from PD using the OCT * establish orthoptic evidence in patients with PD

Registry
clinicaltrials.gov
Start Date
November 5, 2018
End Date
May 26, 2019
Last Updated
7 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Neuromed IRCCS
Responsible Party
Principal Investigator
Principal Investigator

Nicola Modugno

Neurologist, Head of Parkinson Center

Neuromed IRCCS

Eligibility Criteria

Inclusion Criteria

  • Patients aged ≥ 18 years
  • Patients affected by Parkinson's disease (PD) according to the diagnostic criteria of the United Kingdom Brain Bank, in the ON phase of their usual treatment
  • Hoehn-Yahr Stage from 1 to 3
  • Signature of the Informed Consent and of the privacy form

Exclusion Criteria

  • Patients with symptoms and signs compatible with atypical parkinsonism
  • PD patients treated with antagonist drugs for central dopaminergic receptors (first and second generation antipsychotics) in the last 6 months before enrollment
  • Patients suffering from other neurological diseases
  • Patients with evident cognitive impairment (MMSE \<24/30)
  • Patients with manifest eye movement disorders prior to the diagnosis of PD.
  • Patients with daltonism
  • Patients with amblyopia
  • Patients suffering from high anisometropia
  • Patients suffering from advanced cataracts
  • Patients suffering from glaucoma

Outcomes

Primary Outcomes

Inspection of orthoptic condition in patients with PD

Time Frame: through study completion with an avarage of 6 months

Analysis of orthoptic features in patients with PD trough the quantification of the fusional amplitude expressed in prismatic diopters at distance (6 meters) and near (40 cm).

Observation of retinal features in patients with PD through the use of OCT

Time Frame: through study completion with an avarage of 6 months

Registration of the retinal features in patients with PD using OCT trough a quantitative analysis of the macular area and of the optical disc by the registration of retinal tickness expressed in microns for RPE, RNFL and Neuroretine Layer.

Survey the validity of a specific diagnostic protocol for the evaluation of the visual condition in patients with PD.

Time Frame: through study completion with an avarage of 6 months

Review the validity of a specific and integrated ambulatory diagnostic protocol for the study of visual and ophthalmological disorders through a visit protocol and exams designed specifically for patients with PD based on the evidence of visual conditions in the disease currently present in the scientific literature trough the measurement of ocular pressure expressed in mmHg by the use of a Non- Contact Tonometry.

Check the impact of visual condition on the quality of life in patients with PD through the use of questionnaires.

Time Frame: through study completion with an avarage of 6 months

Quantify the impact of visual condition using the VFQ-25 (Visual Functional Questionnaire) in patients with PD through the main method of this questionnaire: all items are scored, each item is then converted to a 0 to 100 scale so that the lowest and highest possible scores are set at 0 and 100 points, respectively so that scores represent the achieved percentage of the total possible score, e.g. a score of 50 represents 50% of the highest possible score. The lowest percentage is the better outcome for the visual condition.

Study Sites (2)

Loading locations...

Similar Trials